Regulatory immune cells in regulation of intestinal inflammatory response to microbiota

Mucosal Immunology

Volumn 8, Issue 5, 2015, Pages 969-978

  Sun, M ^a   He, C ^a,b   Cong, Y ^b   Liu, Z ^a  

^a TONGJI UNIVERSITY   (China)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; CD19 ANTIGEN; CD1D ANTIGEN; CD5 ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; INTERLEUKIN 25; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RETINAL DEHYDROGENASE; SYNDECAN 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN EXPRESSION; B LYMPHOCYTE; BACTEROIDES FRAGILIS; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL STIMULATION; CELLULAR IMMUNITY; CLOSTRIDIA; CYTOKINE RELEASE; DENDRITIC CELL; EFFECTOR CELL; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM; INTESTINE FLORA; LAMINA PROPRIA; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOID CELL; MACROPHAGE; MUCOSAL IMMUNITY; NATURAL KILLER CELL; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TH3 CELL; ADAPTIVE IMMUNITY; ANIMAL; BACTERIUM; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; INTESTINE; MICROBIOLOGY; PATHOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; B-LYMPHOCYTES, REGULATORY; BACTERIA; GASTROINTESTINAL MICROBIOME; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTESTINES; T-LYMPHOCYTES, REGULATORY;

EID: 84939478859     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.49     Document Type: Review

References (107)

1. Garrett, W.S., Gordon, J.I. & Glimcher, L.H. Homeostasis and inflammation in the intestine. Cell 140, 859-870 (2010).
2. Bernstein, C.N., Wajda, A. & Blanchard, J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 129, 827-836 (2005).
3. Wu W. et al. miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD. Gut; advance online publication, 3 October 2014; doi:10.1136/gutjnl-2014-307980
4. Liu, Z. et al. Interleukin (IL)-23 suppresses IL-10 in inflammatory bowel disease. J. Biol. Chem. 287, 3591-3597 (2012).
5. Liu, Z. et al. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. J. Leukoc. Biol. 89, 597-606 (2011).
6. Spits, H. & Cupedo, T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30, 647-675 (2012).
7. Wing, K. & Sakaguchi, S. Regulatory Tcells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13 (2010).
8. Mizoguchi, A.,Mizoguchi, E., Takedatsu,H., Blumberg, R.S. & Bhan, A.K. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 16, 219-230 (2002).
9. Matteoli, G. et al. Gut CD103 dendritic cells express indoleamine 2, 3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 59, 595-604 (2010).
10. Hunter, M.M. et al. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138, 1395-1405 (2010).
11. Cao, A.T., Yao, S., Gong, B., Elson, C.O. & Cong, Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J. Immunol. 189, 4666-4673 (2012).
12. Cao A.T. et al. Interleukin IL)-21 promotes intestinal IgA response to microbiota. Mucosal Immunol; advance online publication, 14 January 2015; doi:10.1038/mi.2014.134 (2015
13. Coccia, M. et al. IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4() Th17 cells. J. Exp. Med. 209, 1595-1609 (2012).
14. Maxwell, J.R. et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J. Immunol. 177, 234-245 (2006).
15. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378 (2010).
16. Grobeta, P., Doser, K., Falk, W., Obermeier, F. & Hofmann, C. IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm. Bowel Dis. 18, 1900-1909 (2012).
17. Schiering,C. et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513, 564-568 (2014).
18. McNamee, E.N. et al. Interleukin 37 expression protects mice wfrom colitis. Proc. Natl. Acad. Sci. USA 108, 16711-16716 (2011).
19. Liu, H. et al. ERK differentially regulates Th17-and Treg-cell development and contributes to the pathogenesis of colitis. Eur. J. Immunol. 43, 1716-1726 (2013).
20. Suzuki, A. et al. CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J. Exp. Med. 193, 471-481 (2001).
21. Sander, L.E. et al. Gp130 signaling promotes development of acute experimental colitis by facilitating early neutrophil/macrophage recruitment and activation. J. Immunol. 181, 3586-3594 (2008).
22. Beagley, K.W. et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169, 2133-2148 (1989).
23. Su, J. et al. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease. Inflamm. Bowel Dis. 19, 720-728 (2013).
24. Van derSluis, M. et al. Muc2-deficientmice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131, 117-129 (2006).
25. Vereecke, L. et al. A20 controls intestinal homeostasis through cellspecific activities. Nat. Commun. 5, 5103 (2014).
26. Vereecke, L. et al. Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis. J. Exp. Med. 207, 1513-1523 (2010).
27. Cheroutre, H., Lambolez, F. & Mucida, D. The light and dark sides of intestinal intraepithelial lymphocytes. Nat. Rev. Immunol. 11, 445-456 (2011).
28. Cheroutre, H. & Lambolez, F. Doubting the TCR coreceptor function of CD8alphaalpha. Immunity 28, 149-159 (2008).
29. Simpson, S.J. et al. Expression of pro-inflammatory cytokines by TCR alpha beta and TCR gamma delta Tcells in an experimental model of colitis. Eur. J. Immunol. 27, 17-25 (1997).
30. Edelblum, K.L. et al. Dynamic migration of gammadelta intraepithelial lymphocytes requires occludin. Proc. Natl. Acad. Sci. USA 109, 7097-7102 (2012).
31. Edelblum, K.L. et al. gd intraepithelial lymphocyte migration limits transepithelial pathogen invasion and systemic disease in mice. Gastroenterology, piiS0016-5085, 00302-00309 (2015).
32. Meehan, T.F. et al. Protection against colitis by CD100-dependent modulation of intraepithelial gammadelta T lymphocyte function. Mucosal Immunol. 7, 134-142 (2014).
33. Chen, Y., Chou, K., Fuchs, E., Havran, W.L. & Boismenu, R. Protection of the intestinal mucosa by intraepithelial gamma delta Tcells. Proc. Natl. Acad. Sci. USA 99, 14338-14343 (2002).
34. Kober O.I. et al. gd T-cell-deficient mice show alterations in mucin expression, glycosylation, and goblet cells but maintain an intact mucus layer. Am. J. Physiol. Gastrointest. Liver Physiol. 306,G582-G593 (2014)
35. Inagaki-Ohara, K. et al. Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J. Immunol. 173, 1390-1398 (2004).
36. Kuhl, A.A. et al. Human peripheral gammadelta Tcells possess regulatory potential. Immunology 128, 580-588 (2009).
37. Denning, T.L. et al. Mouse TCRalphabetaCD8alphaalpha intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses. J. Immunol. 178, 4230-4239 (2007).
38. Poussier, P., Ning, T., Banerjee, D. & Julius, M. A unique subset of selfspecific intraintestinal T cells maintains gut integrity. J. Exp. Med. 195, 1491-1497 (2002).
39. Abbas, A.K. et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat. Immunol. 14, 307-308 (2013).
40. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4 CD25 regulatory T cells. Nat. Immunol. 4, 330-336 (2003).
41. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
42. Bennett, C.L. & Ochs, H.D. IPEX is a unique X-linked syndrome characterized by immune dysfunction, polyendocrinopathy, enteropathy, and a variety of autoimmune phenomena. Curr. Opin. Pediatr. 13, 533-538 (2001).
43. Fantini, M.C. et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4CD25-T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol. 172, 5149-5153 (2004).
44. Shevach, E.M. Mechanisms of foxp3 T regulatory cell-mediated suppression. Immunity 30, 636-645 (2009).
45. Read, S. et al. Blockade of CTLA-4 on CD4CD25 regulatory T cells abrogates their function in vivo. J. Immunol. 177, 4376-4383 (2006).
46. Maul, J. et al. Peripheral and intestinal regulatory CD4 CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128, 1868-1878 (2005).
47. Ehrenstein, M.R. et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200, 277-285 (2004).
48. Ueno, A. et al. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4 T cells and defective suppressive function of circulating Foxp3 regulatory cells support plasticity between Th17 and regulatory Tcells in inflammatory bowel disease patients. Inflamm. Bowel Dis. 19, 2522-2534 (2013).
49. Wu, W. et al. Prolactin mediates psychological stress-induced dysfunction of regulatory Tcells to facilitate intestinal inflammation. Gut 63, 1883-1892 (2014).
50. Veltkamp, C. et al. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFa treatment. Gut 60, 1345-1353 (2011).
51. Boschetti, G. et al. Therapy with anti-TNFalpha antibody enhances number and function of Foxp3() regulatory Tcells in inflammatory bowel diseases. Inflamm. Bowel Dis. 17, 160-170 (2011).
52. Liu, Z., Cao, A.T. & Cong, Y. Microbiota regulation of inflammatory bowel disease and colorectal cancer. Semin. Cancer Biol. 23, 543-552 (2013).
53. Hayashi, A. et al.A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe 13, 711-722 (2013).
54. Ivanov, I.I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485-498 (2009).
55. Round, J.L. & Mazmanian, S.K. Inducible Foxp3 regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107, 12204-12209 (2010).
56. Izcue, A. et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 28, 559-570 (2008).
57. Korn, T. et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells. Nature 448, 484-487 (2007).
58. Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337-341 (2011).
59. Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446-450 (2013).
60. Chang, P.V., Hao, L., Offermanns, S. & Medzhitov, R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc. Natl. Acad. Sci. USA 111, 2247-2252 (2014).
61. Singh, N. et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128-139 (2014).
62. Roncarolo, M.G. et al. Interleukin-10-secreting type 1 regulatory Tcells in rodents and humans. Immunol. Rev. 212, 28-50 (2006).
63. Groux, H. et al. A CD4T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389, 737-742 (1997).
64. Cong, Y., Weaver, C.T., Lazenby, A. & Elson, C.O. Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora. J. Immunol. 169, 6112-6119 (2002).
65. Pestka, S. et al. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22, 929-979 (2004).
66. Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 143, 1207-1217 e1202 (2012).
67. Chen, Y., Kuchroo, V.K., Inobe, J., Hafler,D.A. & Weiner,H.L. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265, 1237-1240 (1994).
68. Carrier, Y., Yuan, J., Kuchroo, V.K. & Weiner, H.L. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta Tcell-transgenic mice. J. Immunol. 178, 179-185 (2007).
69. Fillatreau, S., Sweenie, C.H.,McGeachy,M.J., Gray, D. & Anderton, S.M. Bcells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3, 944-950 (2002).
70. Rosser, E.C. et al. Regulatory B cells are induced by gutmicrobiota-driven interleukin-1beta and interleukin-6 production. Nat. Med. 20, 1334-1339 (2014).
71. Duddy, M. et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J. Immunol. 178, 6092-6099 (2007).
72. Oka, A. et al. Role of regulatory B cells in chronic intestinal inflammation: association with pathogenesis of Crohn's disease. Inflamm. Bowel Dis. 20, 315-328 (2014).
73. Sattler, S. et al. IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut. J. Autoimmun. 50, 107-122 (2014).
74. Lee, J.H. et al. Allergen-specific transforming growth factor-b-producing CD19 () CD5 () regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow's milk. J. Interferon Cytokine Res. 31, 441-449 (2011).
75. Noh, J., Choi, W.S., Noh, G. & Lee, J.H. Presence of Foxp3-expressing CD19()CD5() B cells in human peripheral blood mononuclear cells: human CD19()CD5()Foxp3() regulatory B cell (Breg). Immune. Netw. 10, 247-249 (2010).
76. Ray, A., Basu, S.,Williams, C.B., Salzman, N.H. & Dittel, B.N. A novel IL-10-independent regulatory role forBcells in suppressing autoimmunity by maintenance of regulatory Tcells via GITR ligand. J. Immunol. 188, 3188-3198 (2012).
77. Shen, P. et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 507, 366-370 (2014).
78. Walker, J.A., Barlow, J.L. & McKenzie, A.N. Innate lymphoid cells-how did we miss them? Nat. Rev. Immunol. 13, 75-87 (2013).
79. Tait Wojno, E.D. & Artis, D. Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. Cell Host Microbe 12, 445-457 (2012).
80. Monticelli, L.A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045-1054 (2011).
81. van de Pavert, S.A. et al. Maternal retinoids control type 3 innate lymphoid cells and set the offspring immunity. Nature 508, 123-127 (2014).
82. Hepworth, M.R. et al. Innate lymphoid cells regulate CD4 T-cell responses to intestinal commensal bacteria. Nature 498, 113-117 (2013).
83. Wolk, K. et al. IL-22 increases the innate immunity of tissues. Immunity 21, 241-254 (2004).
84. Sawa, S. et al. RORgammat innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat. Immunol. 12, 320-326 (2011).
85. Spits, H. & Di Santo, J.P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat. Immunol. 12, 21-27 (2011).
86. Mosser, D.M. & Edwards, J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969 (2008).
87. Gordon, S. & Martinez, F.O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604 (2010).
88. Nair, M.G. et al. Alternatively activated macrophage-derived RELM-a is a negative regulator of type 2 inflammation in the lung. J. Exp. Med. 206, 937-952 (2009).
89. Rizzo, A. et al. Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages. Inflamm. Bowel Dis. 18, 449-459 (2012).
90. Kurowska-Stolarska, M. et al. IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J. Immunol. 183, 6469-6477 (2009).
91. Besnard, A.G. et al. IL-33-mediated protection against experimental cerebral malaria is linked to induction of type 2 innate lymphoid cells, M2 macrophages and regulatory Tcells. PLoS Pathog. 11, e1004607 (2015).
92. Byers, D.E. & Holtzman, M.J. Alternatively activated macrophages and airway disease. Chest 140, 768-774 (2011).
93. Smith, P. et al. Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol. 178, 4557-4566 (2007).
94. Summers, R., Elliott, D., Urban, J., Thompson, R. & Weinstock, J. Trichuris suis therapy in Crohn's disease. Gut 54, 87-90 (2005).
95. Vos, A.C. et al. Anti-tumor necrosis factor-alpha antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 140, 221-230 (2011).
96. Ge, R.T. et al. Insulin-like growth factor-1 endues monocyteswith immune suppressive ability to inhibit inflammation in the intestine. Sci. Rep. 5, 7735 (2015).
97. Varol, C. et al. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-512 (2009).
98. Niess, J.H. & Adler, G. Enteric flora expands gut lamina propria CX3CR1 dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions. J. Immunol. 184, 2026-2037 (2010).
99. Atarashi, K. et al. ATP drives lamina propria TH17 cell differentiation. Nature 455, 808-812 (2008).
100. Coombes, J.L. et al. A functionally specialized population of mucosal CD103 DCs induces Foxp3 regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757-1764 (2007).
101. Kayama, H. et al. Intestinal CX3C chemokine receptor 1(high) (CX3CR1(high)) myeloid cells prevent T-cell-dependent colitis. Proc. Natl. Acad. Sci. USA 109, 5010-5015 (2012).
102. Bilsborough, J. & Viney, J.L. In vivo enhancement of dendritic cell function. Ann. NY Acad. Sci. 1029, 83-87 (2004).
103. Clement, M. et al. CD31 is a key coinhibitory receptor in the development of immunogenic dendritic cells. Proc. Natl. Acad. Sci. USA 111, E1101-E1110 (2014).
104. Shan, M. et al. Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342, 447-453 (2013).
105. Kinnebrew, M.A. et al. Interleukin 23 production by intestinal CD103()CD11b() dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense. Immunity 36, 276-287 (2012).
106. Satpathy, A.T. et al. Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens. Nat. Immunol. 14, 937-948 (2013).
107. Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).